Abstract
Goals
The aims of this secondary data analysis were to (a) categorize patterns in the development, duration, intensity, and resolution of sore mouth (which can be considered a proxy for oral mucositis) severity and distress over two cycles of chemotherapy in cancer outpatients and (b) examine the relationship of demographic (age, gender, marital status, and educational level) and disease characteristics (type of cancer and type of chemotherapy) to specific patterns of sore mouth (SM).
Materials and methods
Visual graphical analysis (VGA) was applied to identify individual patterns of SM severity and distress in 51 outpatients receiving chemotherapy who provided daily reports of sore mouth using a computerized interactive voice response system. The majority were female (n = 41, 8%) with a mean age of 53 (SD = 8.35). Most had breast cancer (68%), and one third received chemotherapy with adriamycin and cyclophosphamide (AC). VGA is a technique in which graphs of individual patients’ symptoms are coded for specific individual or group profiles.
Main results
Seven distinct patterns were identified based on variability in onset, duration, and intensity (degree of severity or distress). Chemotherapy agents were significantly associated with patterns of SM. The AC regimen was significantly associated with late onset; however, the intensity did not last long. In contrast, patients receiving R-CHOP were significantly more likely to experience duration intensity (SM after day 15 and a score equal to or greater than a 5 on a 1–10 scale).
Conclusions
VGA revealed symptom patterns often hidden in traditional analysis. Understanding individual variability is important to the design and implementation of future intervention research and clinical care.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00520-008-0509-y/MediaObjects/520_2008_509_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00520-008-0509-y/MediaObjects/520_2008_509_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00520-008-0509-y/MediaObjects/520_2008_509_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00520-008-0509-y/MediaObjects/520_2008_509_Fig4_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00520-008-0509-y/MediaObjects/520_2008_509_Fig5_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00520-008-0509-y/MediaObjects/520_2008_509_Fig6_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00520-008-0509-y/MediaObjects/520_2008_509_Fig7_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00520-008-0509-y/MediaObjects/520_2008_509_Fig8_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00520-008-0509-y/MediaObjects/520_2008_509_Fig9_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00520-008-0509-y/MediaObjects/520_2008_509_Fig10_HTML.gif)
Similar content being viewed by others
References
Brown CG, McGuire DB, Peterson DE, Beck SL, Mooney K (2007) Visual graphical analysis: a technique to investigate symptom trajectories over time. Nurs Res 56:195–201, doi:10.1097/01.NNR.0000270029.82736.5a
Chang VT, Hwang SS, Feuerman M, Kasimis BS (2000) Symptom and quality of life survey of medical oncology patients at a Veterans Affairs Medical Center: a role for symptom assessment. Cancer 88:1175, doi:10.1002/(SICI)1097-0142(20000301)88:5<1175::AID-CNCR30>3.0.CO;2-N
Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M et al (2000) Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 89(7):1634–1646, doi:10.1002/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V
Dodd MJ, Larson PJ, Dibble SL, Miaskowski C, Greenspan D, MacPhail L et al (1996) Randomized clinical trial of clorhexidine versus placebo for prevention for oral mucositis in patients receiving chemotherapy. Oncol Nurs Forum 23:921–927
Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531–1539, doi:10.1002/cncr.11671
McGuire DB, Altomonte V, Peterson DE, Wingard JR, Jones RJ, Grochow LB (1993) Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncol Nurs Forum 20:1493–1502
McGuire DB, Yeager KA, Dudley WN, Peterson DE, Owen DC, Lin LS et al (1998) Acute oral pain and mucositis in bone marrow transplant and leukemia patients: data from a pilot study. Cancer Nurs 21:385–393, doi:10.1097/00002820-199812000-00002
Mooney KH, Beck SL, Friedman RH, Farzanfar R (2002) Telephone-linked care for cancer symptom monitoring. Cancer Pract 10:147–154, doi:10.1046/j.1523-5394.2002.103006.x
Pett MA (1997) Nonparametric statistics for health care research. Sage, Thousand Oaks, CA
Raber-Durlacher JE, Weijl NI, Abu Saris M, de Koning B, Zwinderman AH, Osanto S (2000) Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases. Support Care Cancer 8:366–371, doi:10.1007/s005200050004
Roemer J (1999) An end to outpatient chemotherapy? Medicare takes aim at reimbursement. J Natl Cancer Inst 91:1444–1445, doi:10.1093/jnci/91.17.1444
Scully C, Sonis S, Diz PD (2006) Oral mucositis. Oral Dis 12:229–241, doi:10.1111/j.1601-0825.2006.01258.x
Senn HJ (ed) (2006) Mucositis guidelines: achievements and perspectives. Support Care Cancer 14(6)
Singer JD, Willett JB (2003) Applied longitudinal data analysis: modeling change and event occurrence. Oxford University Press, New York
Sonis SS (2004) A biological approach to mucositis. J Support Oncol 2:21–32
Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patient. Cancer 100:1995–2025, doi:10.1002/cncr.20162
Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T et al (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351:10–18, doi:10.1056/NEJMoa040125
Stiff PJ, Erder H, Bensinger WI, Emmanouilides C, Gentile T, Isitt J et al (2006) Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT). Bone Marrow Transplant 37:393–401, doi:10.1038/sj.bmt.1705250
Vokurka S, Bystricka E, Koza V, Scudlova J, Pavlicova V, Valentova D et al (2006) Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study. Support Care Cancer 14:974–976, doi:10.1007/s00520-006-0031-z
Wong PC, Dodd MJ, Miaskowski C, Paul SM, Bank KA, Shiba GH et al (2006) Mucositis pain induced by radiation therapy: prevalence, severity, and use of self-care behaviors. J Pain Symptom Manage 32:27–37, doi:10.1016/j.jpainsymman.2005.12.020
Youngblut JM, Casper GR (1993) Focus on psychometrics: single-item indicators in nursing research. Res Nurs Health 16:459–465, doi:10.1002/nur.4770160106
Acknowledgments
This research was supported in part by the American Cancer Society Doctoral Scholarship #DSCN-03-203-01 and National Cancer Institute, R25 CA093831. The parent study “Telephone-Linked Care for Symptom Management” (K. Mooney, PI) 1 R01 CA89474, funded) was funded by the NCI.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brown, C.G., Beck, S.L., Peterson, D.E. et al. Patterns of sore mouth in outpatients with cancer receiving chemotherapy. Support Care Cancer 17, 413–428 (2009). https://doi.org/10.1007/s00520-008-0509-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-008-0509-y